过去一年中添加的文章,按日期排序
Abstract LB220: Farnesyltransferase inhibitors show synergistic anticancer effects in combination with novel KRAS G12C inhibitors
J Timar, M Baranyi, E Molnar, I Randelovic… - Cancer Research, 2024 - AACR
121 天前 - … immunotherapy as well as SOS- and SHP2-inhibitors. Based on in-silico analysis
of … compensatory re-activation of HRAS, farnesylation of RHEB in the PI3K/mTOR pathway …
of … compensatory re-activation of HRAS, farnesylation of RHEB in the PI3K/mTOR pathway …
Non-genetic determinants driving the evolutional trajectories of drug-tolerant-persisters in KRAS Non-small cell lung cancer
C Li, CJ Graser, Q Qin, A Nimbalkar, U Syed… - Cancer Research, 2024 - AACR
135 天前 - … inhibitors with drugs that target mitogen-activated protein kinase (MAPK) feedback
reactivation… to therapies targeting different pathways, eg, KRAS+ SHP2, KRAS+CDK4/6, and …
reactivation… to therapies targeting different pathways, eg, KRAS+ SHP2, KRAS+CDK4/6, and …
53P PHI-501 as a potent pan-RAF/DDRs inhibitor suppresses colorectal cancer cell proliferation and overcomes BRAF inhibitor resistance
SM Kim, GJ Sung, S Cho, JH Han, KY Nam, KT Kim… - ESMO Open, 2024 - esmoopen.com
185 天前 - … that PHI-501 inhibited the phosphorylation of MEK, ERK, AKT, and SHP2 proteins in
the … that PHI-501 considerably suppressed the reactivation of pERK and pAKT. In BRAF- or …
the … that PHI-501 considerably suppressed the reactivation of pERK and pAKT. In BRAF- or …
Combining RASG12C(ON) inhibitor with SHP2 inhibition sensitises immune excluded lung tumours to immune checkpoint blockade: a strategy for turning cold …
P Anastasiou, C Moore, S Rana, A de Castro… - bioRxiv, 2024 - biorxiv.org
201 天前 - … reactivation of upstream RTKs which can result in the activation of wild-type and
mutant … we provide evidence that suggests direct effects of SHP2 inhibitor on cells of the TME. …
mutant … we provide evidence that suggests direct effects of SHP2 inhibitor on cells of the TME. …
JC-010a, a novel selective SHP2 allosteric inhibitor, overcomes RTK/non-RTK-mediated drug resistance in multiple oncogene-addicted cancers
X Lu, R Yu, Z Li, M Yang, J Dai, M Liu - Cancer Letters, 2024 - Elsevier
235 天前 - … reactivated ERK upon treatment for 12 h in A549 cells, and SHP2 inhibition by JC-010a
prevented the reactivation … signaling pathways were due to its inhibition effect on SHP2. …
prevented the reactivation … signaling pathways were due to its inhibition effect on SHP2. …
Abstract C141: Targeting SHP2-dependent adaptive resistance to BRAF and MEK inhibition in gliomas
247 天前 - … role of SHP2 upstream of RAS pathway, we postulated that the combination of SHP2i
and BRAFi/MEKi would maintain superior ERK pathway inhibition in … ERK reactivation and …
and BRAFi/MEKi would maintain superior ERK pathway inhibition in … ERK reactivation and …
SHP2 Inhibition Overcomes Adaptive and Acquired Resistance to FLT3 TKI to Improve Efficacy Against FLT3/ITD AML
T Seale, L Li, JK Bruner, B Nguyen, MJ Levis… - Blood, 2023 - Elsevier
250 天前 - … the activation of the ERK pathway. Therefore, we explored … SHP2 inhibitor decreases
the adaptive ERK reactivation … to the versatile efficacy of SHP2 inhibition in multiple AML …
the adaptive ERK reactivation … to the versatile efficacy of SHP2 inhibition in multiple AML …
870 CoREST inhibition by TNG260 increases expression of immunomodulatory genes in STK11-mutant cancer and sensitizes to immune checkpoint blockade
L Ahronian, M Zhang, P Shahagadkar, A Bejnood… - 2023 - jitc.bmj.com
277 天前 - … (ON) inhibitor RM-029 still resulted in RAS pathway reactivation. … pathway. In an
inflamed, anti-PD-1 sensitive mouse model of NSCLC, KRAS G12C (ON) and SHP2 inhibitors …
inflamed, anti-PD-1 sensitive mouse model of NSCLC, KRAS G12C (ON) and SHP2 inhibitors …
[HTML][HTML] 871 Combining KRASG12C (ON) inhibitor with SHP2 and/or immune checkpoint blockade to overcome adaptive resistance and enhance anti-tumour …
P Anastasiou, C Moore, S Rana, J Boumelha… - 2023 - jitc.bmj.com
277 天前 - … of cell viability than the KRAS G12C (OFF) inhibitor MRTX849 in both … ) inhibitor
RM-029 still resulted in RAS pathway reactivation. Addition of RMC-4550 blocked RAS pathway…
RM-029 still resulted in RAS pathway reactivation. Addition of RMC-4550 blocked RAS pathway…
Unravelling Resistance Mechanisms in Philadelphia Positive Leukemias: Targeted Treatment Strategies to Overcome Resistance
G Poudel - 2023 - digital.library.adelaide.edu.au
285 天前 - … on BCR::ABL1 reactivation, the mechanisms of … inhibit this pathway by blocking
BCR::ABL1 and inducing apoptosis in CML cells. However, the activation of the RAS pathway …
BCR::ABL1 and inducing apoptosis in CML cells. However, the activation of the RAS pathway …
相关搜索
- allosteric shp2 inhibition
- shp2 inhibitors adaptive resistance
- shp2 inhibition cold tumours
- shp2 inhibition flt3 tki
- resistance mechanisms shp2 inhibitor
- shp2 inhibition acquired resistance
- shp2 inhibition targeted therapy
- shp2 inhibitors drug resistance
- shp2 inhibitors immune microenvironment
- braf inhibitor paradoxical mapk pathway activation
- shp2 inhibition apoptotic dependency
- shp2 inhibition flt3 itd aml
- shp2 inhibition immune checkpoint blockade
- shp2 inhibitors anti-tumor immunity
- shp2 inhibition solid tumors
- shp2 inhibition cancer cells